U.S. flag

An official website of the United States government

NM_006361.6(HOXB13):c.251G>A (p.Gly84Glu) AND Prostate cancer susceptibility

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Nov 20, 2015
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000210093.6

Allele description [Variation Report for NM_006361.6(HOXB13):c.251G>A (p.Gly84Glu)]

NM_006361.6(HOXB13):c.251G>A (p.Gly84Glu)

Gene:
HOXB13:homeobox B13 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
17q21.32
Genomic location:
Preferred name:
NM_006361.6(HOXB13):c.251G>A (p.Gly84Glu)
Other names:
p.G84E:GGA>GAA
HGVS:
  • NC_000017.11:g.48728343C>T
  • NG_033789.1:g.5407G>A
  • NM_006361.6:c.251G>AMANE SELECT
  • NP_006352.2:p.Gly84Glu
  • NP_006352.2:p.Gly84Glu
  • LRG_771t1:c.251G>A
  • LRG_771:g.5407G>A
  • LRG_771p1:p.Gly84Glu
  • NC_000017.10:g.46805705C>T
  • NM_006361.5:c.251G>A
  • Q92826:p.Gly84Glu
Protein change:
G84E; GLY84GLU
Links:
UniProtKB: Q92826#VAR_071866; OMIM: 604607.0001; dbSNP: rs138213197
NCBI 1000 Genomes Browser:
rs138213197
Molecular consequence:
  • NM_006361.6:c.251G>A - missense variant - [Sequence Ontology: SO:0001583]
Observations:
6

Condition(s)

Name:
Prostate cancer susceptibility
Identifiers:
MedGen: C3469524

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000266072University of Washington Department of Laboratory Medicine, University of Washington
criteria provided, single submitter

(Shirts et al. (Genet Med 2016))
Pathogenic
(Nov 20, 2015)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineno6not providednot provided6not providedclinical testing

Citations

PubMed

Improving performance of multigene panels for genomic analysis of cancer predisposition.

Shirts BH, Casadei S, Jacobson AL, Lee MK, Gulsuner S, Bennett RL, Miller M, Hall SA, Hampel H, Hisama FM, Naylor LV, Goetsch C, Leppig K, Tait JF, Scroggins SM, Turner EH, Livingston R, Salipante SJ, King MC, Walsh T, Pritchard CC.

Genet Med. 2016 Oct;18(10):974-81. doi: 10.1038/gim.2015.212. Epub 2016 Feb 4.

PubMed [citation]
PMID:
26845104

Details of each submission

From University of Washington Department of Laboratory Medicine, University of Washington, SCV000266072.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (1)
2not provided1not providednot providedclinical testing PubMed (1)
3not provided1not providednot providedclinical testing PubMed (1)
4not provided1not providednot providedclinical testing PubMed (1)
5not provided1not providednot providedclinical testing PubMed (1)
6not provided1not providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineno1not providednot provided1not providednot providednot provided
2germlineno1not providednot provided1not providednot providednot provided
3germlineno1not providednot provided1not providednot providednot provided
4germlineno1not providednot provided1not providednot providednot provided
5germlineno1not providednot provided1not providednot providednot provided
6germlineno1not providednot provided1not providednot providednot provided

Last Updated: May 19, 2024